Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-10 5:26 pm Purchase |
2023-08-02 | 13G | Alimera Sciences, Inc. ALIM |
Stonepine Capital Management, LLC | 5,377,711 9.990% |
5,377,711 (New Position) |
Filing History |
| 2023-06-26 5:03 pm Purchase |
2023-06-12 | 13G | Delcath Systems, Inc. DCTH |
Stonepine Capital Management, LLC | 976,008 8.700% |
976,008 (New Position) |
Filing History |
| 2023-06-16 4:54 pm Purchase |
2023-06-19 | 13G | Evolus, Inc. EOLS |
Stonepine Capital Management, LLC | 4,187,447 7.400% |
4,187,447 (New Position) |
Filing History |
| 2023-06-16 4:48 pm Purchase |
2023-06-09 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 563,842 9.990% |
563,842 (New Position) |
Filing History |
| 2023-06-09 4:29 pm Purchase |
2023-05-31 | 13G | SCYNEXIS, Inc. SCYX |
Stonepine Capital Management, LLC | 2,777,877 7.600% |
2,392,227 (+620.31%) |
Filing History |
| 2023-04-28 6:31 pm Purchase |
2023-04-19 | 13G | aTyr Pharma, Inc. ATYR |
Stonepine Capital Management, LLC | 4,743,162 4.400% |
4,743,162 (New Position) |
Filing History |
| 2023-04-14 08:25 am Purchase |
2023-04-04 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 7,018,046 5.300% |
1,353,946 (+23.90%) |
Filing History |
| 2023-02-17 5:04 pm Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
Stonepine Capital Management, LLC | 4,569,433 8.900% |
4,569,433 (New Position) |
Filing History |
| 2023-02-13 10:58 am Sale |
2022-12-31 | 13G | Exagen Inc. XGN |
Stonepine Capital Management, LLC | 854,042 5.200% |
-4,525 (-0.53%) |
Filing History |
| 2023-02-13 10:57 am Purchase |
2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Stonepine Capital Management, LLC | 11,195,189 8.200% |
4,704,090 (+72.47%) |
Filing History |
| 2023-02-13 10:57 am Purchase |
2022-12-31 | 13G | UroGen Pharma Ltd. URGN |
Stonepine Capital Management, LLC | 1,304,947 5.700% |
108,039 (+9.03%) |
Filing History |
| 2023-02-13 10:56 am Purchase |
2022-12-31 | 13G | Conformis, Inc. CFMS |
Stonepine Capital Management, LLC | 748,194 9.900% |
748,194 (New Position) |
Filing History |
| 2023-02-13 10:55 am Sale |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 6,940,000 3.100% |
-2,971,577 (-29.98%) |
Filing History |
| 2023-02-13 10:35 am Purchase |
2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Stonepine Capital Management, LLC | 4,351,088 9.000% |
1,695,959 (+63.87%) |
Filing History |
| 2023-02-13 10:29 am Purchase |
2022-12-31 | 13G | Rezolute, Inc. RZLT |
Stonepine Capital Management, LLC | 3,021,504 8.200% |
2,213,099 (+273.76%) |
Filing History |
| 2023-02-13 10:28 am Sale |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
Stonepine Capital Management, LLC | 0 0.000% |
-4,006,185 (Position Closed) |
Filing History |
| 2023-02-13 10:27 am Sale |
2022-12-31 | 13G | CTI BioPharma Corp. CTIC |
Stonepine Capital Management, LLC | 5,664,100 4.500% |
-4,090,835 (-41.94%) |
Filing History |
| 2023-02-13 10:24 am Purchase |
2022-12-31 | 13G | Amryt Pharma plc AMYT |
Stonepine Capital Management, LLC | 31,666,195 9.900% |
1,317,320 (+4.34%) |
Filing History |
| 2023-01-18 6:03 pm Purchase |
2023-01-09 | 13G | Third Harmonic Bio, Inc. THRD |
Stonepine Capital Management, LLC | 2,152,968 5.300% |
2,152,968 (New Position) |
Filing History |
| 2022-12-02 11:15 am Purchase |
2022-11-22 | 13G | UroGen Pharma Ltd. URGN |
Stonepine Capital Management, LLC | 1,196,908 5.200% |
1,196,908 (New Position) |
Filing History |